Purple Biotech Ltd.PPBTNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +58.71% | +60.45% | +94.27% | +98.83% | +64.29% |
| Weighted Average Shares Diluted Growth | +58.69% | +59.08% | +94.17% | +98.77% | +64.32% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -22.46% | -16.40% | -10.71% | -4.68% | +11.27% |
| Book Value per Share Growth | -51.99% | -40.13% | -45.82% | -45.09% | -32.17% |
| Debt Growth | -40.00% | -47.86% | -55.37% | -60.54% | +15.32% |
| R&D Expense Growth | -70.63% | -91.26% | -77.80% | -76.87% | -56.25% |
| SG&A Expenses Growth | -32.21% | -62.61% | -38.06% | -21.04% | -7.60% |